Expression analysis of candidate breast tumour suppressor genes on chromosome 16q
-
* Corresponding author: Tom van Wezel t.van_wezel@lumc.nl
Breast Cancer Research 2005, 7:R998-R1004 doi:10.1186/bcr1337
Accesses
- Last 30 days: 73 accesses
- Last 365 days: 734 accesses
- All time: 5591 accesses
Cited by
BioMed Central: 3 citations
|
Expression of the Epigenetic factor BORIS (CTCFL) in the Human Genome Rosalia de Necochea-Campion, Anahit Ghochikyan, Steven F Josephs, Shelly Zacharias, Erik Woods, Feridoun Karimi-Busheri, Doru T Alexandrescu, Chien-Shing Chen, Michael G Agadjanyan, Ewa Carrier Journal of Translational Medicine 2011, 9:213 (14 December 2011) |
|
Anne-Marie Cleton-Jansen, Ronald van Eijk, Marcel Lombaerts, Marjanka K Schmidt, Laura J Van't Veer, Katja Philippo, Rhyenne ME Zimmerman, Johannes L Peterse, Vincent TBHM Smit, Tom van Wezel, Cees J Cornelisse BMC Cancer 2008, 8:105 (16 April 2008) |
|
Breast tumor copy number aberration phenotypes and genomic instability Jane Fridlyand, Antoine M Snijders, Bauke Ylstra, Hua Li, Adam Olshen, Richard Segraves, Shanaz Dairkee, Taku Tokuyasu, Britt Ljung, Ajay N Jain, Jane McLennan, John Ziegler, Koei Chin, Sandy Devries, Heidi Feiler, Joe W Gray, Frederic Waldman, Daniel Pinkel, Donna G Albertson BMC Cancer 2006, 6:96 (18 April 2006) Analysis of DNA copy number alterations reveals three subtypes of breast tumors differing in numbers and types of aberrations; deregulation of E2F and telomere dysfunction were associated with greater genomic instability.
|